Literature DB >> 27515982

Rapidly progressive diffuse systemic sclerosis after local vitamins A, D and E complex injections: literature review and report of two cases.

Gustavo Guimarães Moreira Balbi1, Ricardo Azêdo Montes2, Verônica Silva Vilela2, Marcella Azevedo Borges Andrade2, Monisa Martins Nóbrega3, Luna Azulay-Abulafia3, Roberto Souto da Silva3, Evandro Mendes Klumb2, Roger Abramino Levy2.   

Abstract

The term autoimmune/autoinflammatory syndrome induced by adjuvants (ASIA) or Shoenfeld's syndrome refers to a wide group of immune-mediated diseases triggered by external agents. Several substances, such as vaccine adjuvants, squalene and silicone implants, are implied in the pathogenesis of ASIA syndrome. Treatment and prognosis of this complex condition are not completely known due to lack of good quality evidence. After a brief introductory literature review on ASIA, we report here two cases of patients that developed rapidly progressive systemic sclerosis clinical features after multiple intramuscular local injections of a substance recommended by a non-medical professional called ADE. ADE is an oily vitamin complex for veterinary use, and it was used in these cases for cosmetic muscular definition and enhancement purpose. To our knowledge, this is the first paper to describe the relation between injections of ADE and the development of ASIA with severe systemic sclerosis phenotype. Further investigation is needed to better understand the pathophysiology and to provide the basis for the treatment of this condition.

Entities:  

Keywords:  ADE; Autoimmune/autoinflammatory syndrome induced by adjuvants (ASIA); Shoenfeld’s syndrome; Systemic sclerosis

Mesh:

Substances:

Year:  2017        PMID: 27515982     DOI: 10.1007/s12026-016-8851-5

Source DB:  PubMed          Journal:  Immunol Res        ISSN: 0257-277X            Impact factor:   2.829


  24 in total

1.  'ASIA': a new systemic autoimmune syndrome?

Authors:  R Cervera
Journal:  Lupus       Date:  2011-04-19       Impact factor: 2.911

2.  Infections, vaccines and autoimmunity.

Authors:  Y Shoenfeld
Journal:  Lupus       Date:  2009-11       Impact factor: 2.911

3.  Antibodies to squalene in Gulf War syndrome.

Authors:  P B Asa; Y Cao; R F Garry
Journal:  Exp Mol Pathol       Date:  2000-02       Impact factor: 3.362

4.  Meta-analyses of the relation between silicone breast implants and the risk of connective-tissue diseases.

Authors:  E C Janowsky; L L Kupper; B S Hulka
Journal:  N Engl J Med       Date:  2000-03-16       Impact factor: 91.245

Review 5.  Oily adjuvants and autoimmunity: now time for reconsideration?

Authors:  M Whitehouse
Journal:  Lupus       Date:  2012-02       Impact factor: 2.911

Review 6.  Silicone and scleroderma revisited.

Authors:  M Lidar; N Agmon-Levin; P Langevitz; Y Shoenfeld
Journal:  Lupus       Date:  2012-02       Impact factor: 2.911

Review 7.  Silicone gel breast implants and connective tissue disease--a comprehensive review.

Authors:  Eran Bar-Meir; Michael Eherenfeld; Yehuda Shoenfeld
Journal:  Autoimmunity       Date:  2003-06       Impact factor: 2.815

Review 8.  Vaccination and autoimmune rheumatic diseases.

Authors:  Fabrizio Conti; Soheila Rezai; Guido Valesini
Journal:  Autoimmun Rev       Date:  2008-12       Impact factor: 9.754

9.  Autoimmune/inflammatory syndrome induced by adjuvants (ASIA) due to silicone implant incompatibility syndrome in three sisters.

Authors:  R M Kappel; J W Cohen Tervaert; G J M Pruijn
Journal:  Clin Exp Rheumatol       Date:  2014-04-09       Impact factor: 4.473

10.  Human papillomavirus vaccine and systemic lupus erythematosus.

Authors:  Mariele Gatto; Nancy Agmon-Levin; Alessandra Soriano; Raffaele Manna; Ramit Maoz-Segal; Shaye Kivity; Andrea Doria; Yehuda Shoenfeld
Journal:  Clin Rheumatol       Date:  2013-04-28       Impact factor: 3.650

View more
  1 in total

1.  Novel clinical and therapeutic aspects in autoimmunity.

Authors:  Howard Amital; Abdulla Watad; Zoltán Szekanecz
Journal:  Immunol Res       Date:  2017-02       Impact factor: 2.829

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.